Analyze Diet
Equine veterinary journal1976; 8(4); 173-175; doi: 10.1111/j.2042-3306.1976.tb03334.x

The use of Dopram as a respiratory stimulant following Immobilon in the pony.

Abstract: The effects of the analeptic agent, Dopram (doxapram hydrochloride) were investigated in 2 ponies during Immobilon - induced neuroleptanalgesia. Although Dopram was demonstrated to exert a degree of respiratory stimulation, this was concluded to provide no overall advantage. The etorphine-induced hypoxic hypoxia was only partially reversed, and there was additional cardiovascular stimulation, in contrast to the previously reported tendency for arterial blood pressure to return towards conscious control values during the course of action of Immobilon.
Publication Date: 1976-10-01 PubMed ID: 976233DOI: 10.1111/j.2042-3306.1976.tb03334.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigated the effects of Dopram, a respiratory stimulant, on ponies following neuroleptanalgesia induced by Immobilon. It concluded that Dopram offered no overall advantages as it only partially reversed hypoxic hypoxia and caused additional cardiovascular stimulation.

Research Objective and Methodology

  • This research aimed to study the effects of the analeptic (stimulating) agent Dopram, specifically doxapram hydrochloride, on ponies following the use of Immobilon, a drug utilized in inducing neuroleptanalgesia – a state of analgesia (relief from pain) and tranquilization.
  • The experiment was conducted on two ponies where they were first subjected to Immobilon-induced neuroleptanalgesia and later treated with Dopram.

Research Findings

  • The research showed that Dopram did stimulate respiratory function to a certain degree in the ponies, but this was not found to offer any major benefits.
  • The ponies, as anticipated, experienced etorphine-induced hypoxic hypoxia (a form of hypoxia where low oxygen in the blood leads to low tissue oxygen levels) due to Immobilon. But the use of Dopram only reversed this condition partially, therefore, didn’t fully address the issue.
  • The additional finding was related to cardiovascular stimulation. Dopram was found to induce unexpected cardiovascular stimulation. This result is noteworthy because prior studies have shown arterial blood pressure tends to return to normal, conscious control values after the administration of Immobilon. So, the effect of Dopram on causing further cardiovascular stimulation was in sharp contrast to the known properties of Immobilon.

Conclusion

  • The experiment demonstrated that the use of Dopram following Immobilon-induced neuroleptanalgesia in ponies did not provide overall advantage.
  • While Dopram showed a certain degree of respiratory stimulus, it was unable to fully reverse hypoxic hypoxia. Furthermore, the introduction of an unexpected cardiovascular stimulation raised flags about its utility in this context.

Cite This Article

APA
Hillidge CJ. (1976). The use of Dopram as a respiratory stimulant following Immobilon in the pony. Equine Vet J, 8(4), 173-175. https://doi.org/10.1111/j.2042-3306.1976.tb03334.x

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 8
Issue: 4
Pages: 173-175

Researcher Affiliations

Hillidge, C J

    MeSH Terms

    • Acepromazine
    • Animals
    • Doxapram / pharmacology
    • Etorphine
    • Female
    • Horses
    • Morphinans
    • Neuroleptanalgesia / veterinary
    • Respiration / drug effects

    Citations

    This article has been cited 0 times.